Test Price
1,200 AED✅ Home Collection Available
H9N7 and Influenza A RNA Detection Qualitative Test in UAE | 1,200 AED | DHA Licensed Laboratory
Executive Summary & Core Metrics
- Diagnostic Accuracy: 99.9% clinical sensitivity and specificity via ISO-accredited real-time PCR and whole genome sequencing.
- Specimen Collection: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection, available daily from 8 AM to 11 PM.
- Results Delivery: Phone result within 36 hours; detailed email report within 48 working hours.
- Insurance & Billing: Direct billing verification via WhatsApp at +971 54 548 8731.
- Clinical Oversight: Post-test telephonic guidance provided by a licensed general practitioner.
Test Overview & Methodology
This qualitative molecular assay detects H9N7 avian influenza virus RNA and Influenza A virus RNA in respiratory specimens using real-time PCR (qPCR) coupled with whole genome sequencing (WGS). The method provides definitive differentiation between novel avian influenza strains and seasonal influenza A, enabling precise clinical management. Testing is performed at DNA Labs UAE, a DHA-licensed facility (License No. 1143) under strict ISO 9001:2015 quality management protocols.
| Feature | Our Test (1,200 AED) | Standard Rapid Antigen Test |
|---|---|---|
| Technology | Real-Time PCR (qPCR) & WGS | Lateral Flow Immunoassay |
| Target | Viral RNA (H9N7 & Influenza A) | Viral nucleoprotein antigen |
| Sensitivity / Specificity | 99.9% clinical sensitivity | 70–80% sensitivity |
| Turnaround Time | 36 h (phone) / 48 h (email) | 15–30 minutes |
| ISO Accreditation | ISO 9001:2015 certified | Often uncertified |
| Home Collection | VIP cold-chain courier | Self-administered |
Physician Insight & Safety Protocols
"As a general practitioner registered with the Dubai Health Authority (DHA ID: 36234132), I emphasize that a positive H9N7 or Influenza A RNA result must be interpreted in conjunction with clinical symptoms, exposure history, and radiographic findings. Patients should never self-prescribe antivirals or modify existing treatment regimens without direct consultation. Our laboratory ensures that every result is accompanied by a telephonic clinical summary to support informed decision-making."
— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132
Safety Advisory & Specimen Handling
Critical Clinical Precautions
- Do not discontinue, adjust, or initiate any antiviral medication without explicit instruction from your treating physician.
- A positive molecular result does not differentiate between active replicating infection and non-viable viral shedding; clinical correlation is mandatory.
- Patients with severe respiratory distress, hypoxia, or hemodynamic instability should seek emergency care immediately.
Specimen Collection Exclusion Criteria
Exclusions & Red Flags
- Asymptomatic individuals without documented high-risk exposure may have collection deferred pending physician assessment.
- Patients unable to provide an adequate respiratory specimen (e.g., severe respiratory compromise impeding sputum or swab collection) are excluded from home phlebotomy.
- Individuals lacking capacity to provide informed consent, unless a legally authorized representative is present.
- Emergency warning signs: acute shortness of breath, persistent chest pain, cyanosis, confusion, or decreased consciousness — immediate hospital care required.
Patient FAQ & Clinical Guidance
1. What is the H9N7 and Influenza A RNA Qualitative Test?
This is a molecular diagnostic test that uses real-time PCR and whole genome sequencing to detect the genetic material of H9N7 avian influenza virus and Influenza A virus directly from a respiratory specimen. It provides a definitive yes/no answer regarding active infection with these viral strains.
2. How should I prepare for the sample collection?
No special preparation is required. Avoid eating or drinking for 30 minutes prior to a nasopharyngeal swab collection. Our trained phlebotomist will use a sterile swab to collect the specimen from your nasal cavity or throat, following ISO-certified cold-chain protocols to preserve RNA integrity.
3. How long does it take to get my results?
Preliminary phone results are available within 36 hours of sample receipt. A comprehensive emailed PDF report with clinical interpretation notes is delivered within 48 working hours. Expedited processing is available upon request.
4. Is home collection available for this test?
Yes. Our VIP Mobile Phlebotomy service operates daily from 8 AM to 11 PM. A licensed healthcare professional visits your home using temperature-controlled cold-chain transport to ensure specimen stability. This service is available across all major UAE emirates.
5. Will my health insurance cover the test cost?
Coverage depends on your individual insurance policy. DNA Labs UAE offers direct billing verification — send your policy details via WhatsApp to +971 54 548 8731, and our team will confirm coverage and any out-of-pocket costs before sample collection.
UAE Regulatory & Data Privacy Adherence
Data Protection & Legal Compliance
DNA Labs UAE operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data, including test results and personal identifiers, are encrypted in transit and at rest, accessed only by authorized clinical personnel under strict confidentiality agreements.
Clinical testing safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Every patient provides written informed consent prior to specimen collection, and all results are disclosed directly to the ordering physician or the patient through a verified channel.
ISO 9001:2015 Certified — Certificate No. INT/EGQ/2509DA/3139. DHA Facility License No. 1143.
Clinical & Logistical Metadata
| Test Name | H9N7 and Influenza A RNA Detection (Qualitative) |
| Price (AED) | 1,200 AED |
| Turnaround Time | 36 hours (phone) / 48 hours (email report) |
| Sample Type / Matrix | Respiratory Specimen (Nasopharyngeal Swab, Sputum, or Bronchoalveolar Lavage) |
| Methodology Used | Real-Time PCR (qPCR) & Whole Genome Sequencing (WGS) |
| ICD-10-CM Code | J09.X9 |
| LOINC Code | 80293-4 |
| DHA Facility License & Address | DHA License No. 1143 | DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians